A TPM2 mutation causes congenital myopathy with fibre-type disproportion

Paulo José Lorenzoni1, Luciane Filla2, Renata Dal-Prá Ducci2

  • 1Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, 80060-900, Brazil. lorenzoni@ufpr.br.

Insights

This study details a rare case of congenital fibre-type disproportion (CFTD) in a 9-year-old girl, linked to a specific TPM2 gene variant. This finding expands understanding of genetic causes for early-onset muscle weakness.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Congenital fibre-type disproportion (CFTD) is a rare neuromuscular disorder characterized by distinct differences in muscle fiber types.
  • Early diagnosis and genetic identification are crucial for understanding disease progression and potential therapeutic targets.

Observation:

  • A 9-year-old girl presented with delayed motor milestones, respiratory issues, hypotonia, generalized muscle wasting, dysphagia, and facial weakness since birth.
  • Muscle biopsy of the biceps brachii confirmed congenital fibre-type disproportion (CFTD).

Findings:

  • Sanger sequencing identified a pathogenic variant (c.415_417delGAG; p.Glu139del) in the beta-tropomyosin (TPM2) gene.
  • This specific TPM2 gene variant (p.Glu139del) has been previously associated with CFTD in only one other reported case, highlighting its rarity.

Implications:

  • This case underscores the importance of genetic testing in diagnosing rare neuromuscular disorders like CFTD.
  • Further research into the TPM2 gene and its variants can elucidate mechanisms underlying congenital myopathies and inform future genetic counseling and treatment strategies.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
139
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.0K